The specialty of allergy and clinical immunology in Brazil
- PMID: 35935019
- PMCID: PMC9347215
- DOI: 10.3389/falgy.2022.933816
The specialty of allergy and clinical immunology in Brazil
Abstract
Objective: To assess the profile of allergist/immunologist (A/I) physicians in Brazil, the workplace, the access to diagnostic and therapeutic procedures, and the impact of the COVID-19 pandemic on professional practice.
Methods: This cross-sectional study was conducted as an online survey. All adhering members of the Brazilian Association of Allergy and Immunology (ASBAI) received a Google Forms tool by email. The questionnaire addressed sociodemographic and professional aspects of the Brazilian allergists/immunologists (A/I) daily routine. The information was analyzed by SPSS version 20.0.
Results: Four hundred and sixty members answered the questionnaire. Women were predominant among the responders (336; 73%), and the median age was 47 years (range, 27-82 years). Most participants worked in the private sector (437, 95%), whereas 256 (47%) worked in the public sector. Among the public sector employees, 210 (82%) reported having access to some diagnostic test for allergic diseases and inborn errors of immunity. Only 91 (35%) A/I physicians in the public system had access to allergen-specific immunotherapy, compared to 416 (95, 9%) of those in the private sector. Regarding biological drugs, 135 (52.7%) and 314 (71.9%) of the A/I physicians working in the public and private sector, respectively, reported access. Two hundred and eighty-three (61.6%) had at least a 50% reduction in the number of consultations, and 245 (56%) provided telemedicine care during the COVID-19 pandemic.
Conclusion: Brazilian A/I have incorporated the most recent advances in managing immunoallergic diseases into their clinical practice, but they still have little access to various diagnostic methods. Strategies to enable the presence of A/I in public health services should be discussed and implemented. The coronavirus pandemic has accelerated the incorporation of telemedicine as a viable and promising method of medical care and can expand access to the specialty.
Keywords: allergy and immunology; health policies; integral health care; professional profile; telemedicine.
Copyright © 2022 de Mello, Serpa, Chiabai, Fernandes, Chong-Neto, Sarinho, Rubini and Solé.
Figures
References
-
- ASBAI. Brazilian Association of Allergy and Immunology (2021). Available online at: https://asbai.org.br/missao-visao-e-valores/ (accessed August 12, 2021).
-
- Serpa FS, Urrutia-Pereira M, Costa E, Digesu RW, Guidacci MFRC, Cruz AS, et al. The allergy and clinical immunology specialty in the different levels of health care in Brazil. Arq Asma AlergImunol. (2018) 2:335–43. 10.5935/2318-5015.20180040 - DOI
-
- WHO. Director-General's opening remarks at the media briefing on COVID19—March 2020 (2020). Available online at: https://www.who.int/director-general/speeches/detail/who-director-genera... (accessed August 12, 2021).
LinkOut - more resources
Full Text Sources
